| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.6 |